Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

144 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia.
Ballantyne CM, Vasas S, Azizad M, Clifton P, Rosenson RS, Chang T, Melquist S, Zhou R, Mushin M, Leeper NJ, Hellawell J, Gaudet D. Ballantyne CM, et al. Among authors: leeper nj. N Engl J Med. 2024 Sep 12;391(10):899-912. doi: 10.1056/NEJMoa2404143. Epub 2024 May 28. N Engl J Med. 2024. PMID: 38804517 Clinical Trial.
Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk.
Watts GF, Rosenson RS, Hegele RA, Goldberg IJ, Gallo A, Mertens A, Baass A, Zhou R, Muhsin M, Hellawell J, Leeper NJ, Gaudet D; PALISADE Study Group. Watts GF, et al. Among authors: leeper nj. N Engl J Med. 2024 Sep 2. doi: 10.1056/NEJMoa2409368. Online ahead of print. N Engl J Med. 2024. PMID: 39225259
Pro-efferocytic nanotherapies reduce vascular inflammation without inducing anemia in a large animal model of atherosclerosis.
Bamezai S, Zhang Y, Kumari M, Lotfi M, Alsaigh T, Luo L, Kumar GS, Wang F, Ye J, Puri M, Manchanda R, Paluri S, Adkar SS, Kojima Y, Ingelsson A, Bell CF, Lopez NG, Fu C, Choi RB, Miller Z, Barrios L, Walsh S, Ahmad F, Maegdefessel L, Smith BR, Leeper NJ. Bamezai S, et al. Among authors: leeper nj. Nat Commun. 2024 Sep 13;15(1):8034. doi: 10.1038/s41467-024-52005-1. Nat Commun. 2024. PMID: 39271657 Free PMC article.
Characterization of peripheral artery disease and associations with traditional risk factors, mobility, and biomarkers in the project baseline health study.
Kercheval JB, Narcisse DI, Nguyen M, Rao SV, Gutierrez JA, Leeper NJ, Maron DJ, Rodriguez F, Hernandez AF, Mahaffey KW, Shah SH, Swaminathan RV; Project Baseline Health Study Group. Kercheval JB, et al. Among authors: leeper nj. Am Heart J. 2024 Sep;275:183-190. doi: 10.1016/j.ahj.2024.06.010. Epub 2024 Jul 3. Am Heart J. 2024. PMID: 38969081
Multiplex Imaging for Cell Phenotyping of Early Human Atherosclerosis.
Elishaev M, Li B, Zhou A, Salim K, Leeper NJ, Francis GA, Lai C, Wang Y. Elishaev M, et al. Among authors: leeper nj. J Am Heart Assoc. 2024 Jun 18;13(12):e034990. doi: 10.1161/JAHA.123.034990. Epub 2024 Jun 6. J Am Heart Assoc. 2024. PMID: 38842292 Free PMC article.
Cancer Incidence After Diagnosis of Abdominal Aortic Aneurysm-Brief Report.
Luo L, Haas AM, Bell CF, Baylis RA, Adkar SS, Fu C, Angelov I, Giordano SH, Klarin D, Leeper NJ, Nead KT. Luo L, et al. Among authors: leeper nj. Arterioscler Thromb Vasc Biol. 2024 Jul;44(7):1694-1701. doi: 10.1161/ATVBAHA.123.320543. Epub 2024 May 23. Arterioscler Thromb Vasc Biol. 2024. PMID: 38779853 Free article.
Peripheral Artery Disease: Molecular Mechanisms and Novel Therapies.
Athavale A, Fukaya E, Leeper NJ. Athavale A, et al. Among authors: leeper nj. Arterioscler Thromb Vasc Biol. 2024 Jun;44(6):1165-1170. doi: 10.1161/ATVBAHA.124.320195. Epub 2024 May 22. Arterioscler Thromb Vasc Biol. 2024. PMID: 38776386 Free article. Review. No abstract available.
144 results